These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8621590)

  • 21. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
    Richards RG; Walker MP; Sebastian J; DiAugustine RP
    J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblasts.
    Winnay JN; Brüning JC; Burks DJ; Kahn CR
    J Biol Chem; 2000 Apr; 275(14):10545-50. PubMed ID: 10744748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
    Tanaka M; Gupta R; Mayer BJ
    Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo regulation of CrkII and CrkL proto-oncogenes in the uterus by insulin-like growth factor-I. Differential effects on tyrosine phosphorylation and association with paxillin.
    Butler AA; Blakesley VA; Koval A; deJong R; Groffen J; LeRoith D
    J Biol Chem; 1997 Oct; 272(44):27660-4. PubMed ID: 9346905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction.
    Koval AP; Karas M; Zick Y; LeRoith D
    J Biol Chem; 1998 Jun; 273(24):14780-7. PubMed ID: 9614078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
    Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
    Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B; Leventhal PS; White MF; Feldman EL
    Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of IRS-1-GRB-2 complexes in insulin signaling.
    Myers MG; Wang LM; Sun XJ; Zhang Y; Yenush L; Schlessinger J; Pierce JH; White MF
    Mol Cell Biol; 1994 Jun; 14(6):3577-87. PubMed ID: 8196603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
    Matsuda M; Ota S; Tanimura R; Nakamura H; Matuoka K; Takenawa T; Nagashima K; Kurata T
    J Biol Chem; 1996 Jun; 271(24):14468-72. PubMed ID: 8662907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
    Boney CM; Gruppuso PA; Faris RA; Frackelton AR
    Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
    Smit L; van der Horst G; Borst J
    J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.